Related Experiment Videos
Insulin-resistant diabetes during growth hormone therapy in a child with SHORT syndrome
C F Verge1, K C Donaghue, P F Williams
1Ray Williams Institute of Paediatric Endocrinology, Royal Alexandra Hospital for Children, Sydney, Australia.
Acta Paediatrica (Oslo, Norway : 1992)
|July 1, 1994
Abstract:
We report the case of a 13-year-old boy with SHORT syndrome, including lipoatrophy and insulin resistance, who developed diabetes mellitus while receiving growth hormone therapy. The diabetes persisted after cessation of exogenous growth hormone but oral hypoglycaemic therapy was successful and could be discontinued eight months later.